The upcoming Greater Philadelphia Business Coalition on Health (GPBCH) 2024 Mental Health Summit aims to address the growing recognition among employers of the critical role mental health plays in workplace productivity and overall well-being.
The upcoming Greater Philadelphia Business Coalition on Health (GPBCH) 2024 Mental Health Summit aims to address the growing recognition among employers of the critical role mental health plays in workplace productivity and overall well-being, according to GPBCH President and CEO Neil Goldfarb.
Over the past decade, workplace culture has shifted from focusing primarily on physical health to embracing a more holistic view of well-being, including mental health. Employers now understand that addressing mental health concerns, like depression and anxiety, can reduce both direct and indirect costs while fostering a healthier, more productive workforce. However, many still struggle with effectively implementing strategies that create a supportive culture and leverage existing resources like Employee Assistance Programs (EAPs). This summit seeks to provide practical solutions and tools to address these challenges.
The event will feature a 3-part agenda designed to guide employers through understanding workforce mental health needs, building a culture around health, and exploring innovative treatment approaches. The program includes sessions on generational differences in mental health needs, the role of coaching and peer support, and advancements such as prescription digital therapeutics and psychedelics.
The daylong meeting will conclude with a panel of employers sharing their experiences, challenges, and best practices. Attendees will leave with actionable strategies to enhance mental health support in the workplace, often by maximizing existing resources in innovative ways.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
ERISA Industry Committee Sues Minnesota Over PBM Law
January 3rd 2025The Employee Retirement Income Security Act (ERISA) Industry Committee filed a legal challenge against the Minnesota Department of Commerce, arguing that Minnesota’s Pharmacy Benefit Manager (PBM) Licensure and Regulation Act illegally interfered with employer-sponsored health plans by restricting plan design options and increasing costs.
Read More
Dr Yehuda Handelsman: DCRM Guidelines Are Shaping Integrated, Global CRM Care
January 3rd 2025In part 2 of our interview, Yehuda Handelsman, MD, discusses how cardiorenalmetabolic (CRM) disease management is advancing with the 2022 Diabetes, Cardiorenal, and Metabolic (DCRM) multispecialty practice recommendations and the updated DCRM 2.0 guidelines.
Read More